January 30, 2019
CBT-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
Read More
January 30, 2019
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Read More
January 30, 2019
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Read More
January 30, 2019
CBT-501 or Nivolumab in Combination With CBT-101 in Locally Advanced or Metastatic HCC and RCC
Read More
January 30, 2019
CBT-501 or Nivolumab in Combination With CBT-101 in Locally Advanced or Metastatic HCC and RCC
Read More
X